In this recorded webinar, a subject matter expert from the Opioid Response Network, discussed how health care providers can become certified to provide medication-assisted treatment (MAT) and medications for medication for opioid use disorder (MOUD).

In this recorded webinar, a subject matter expert from the Opioid Response Network, identified workflows to help providers screen people for substance use disorders. Participants also explored how motivational interviewing can help strengthen a person's motivation to fight addiction.

This webinar focuses on the American Society of Addiction Medicine's outpatient addiction treatment levels. This is the fourth of the eight-part webinar series, Current and Emerging Health Issues Related to Opioid Use and Substance Use. The webinar also addresses how to address opioid use disorder in a general medical setting.

In this recorded webinar, a subject matter expert from the Opioid Response Network, defines chronic pain and describes the challenges in long-term treatment for those with chronic pain. Participants also reviewed alternatives to using prescription medications to treat pain.

In September 2023, the Agency for Healthcare Research and Quality released its latest "rapid evidence reports" on patient safety practices. Patient and family engagement is among the topics addressed in the reports. This website outlines this research protocol and its findings.

Listen and learn from nationally recognized experts in four, 15-minute podcasts about the importance and effectiveness of starting buprenorphine treatment for opioid use disorder in emergency departments.

New approaches to managing pain are included in this 50-page eBook from the National Center for Complementary and Integrative Health (NCCIH). The NCCIH publication, which can be downloaded, provides an overview of complementary health approaches for pain, including acupuncture, massage therapy, meditation, spinal manipulation, yoga and more.

This recorded webinar focuses on evidence-based medical and behavioral interventions to treat opioid and substance use disorder. This is the second of a nine-part webinar series, Current and Emerging Health Issues Related to Opioid Use and Substance Use. The webinar also addresses the three phases of addiction and how the brain is affected by substance use.

This recorded webinar addresses the role emergency departments can play when dealing with public health issues, like opioid use disorder. This is the seventh of a nine-part webinar series, Current and Emerging Health Issues Related to Opioid Use and Substance Use.

In this recorded webinar, Dr. Michael Weaver discussed the FDA-approved medications for addiction treatment (MAT). Dr. Weaver also shared an example of a successful MAT treatment program that can be used in various health care settings. This webinar is the third in a nine-part series, Current & Emerging Health Issues Related to Opioid Use & Substance Use.

For many individuals with opioid use disorder (OUD), initial contact with the health care system occurs in the emergency department (ED) while experiencing an overdose or withdrawal symptoms. This overview of five case studies provides an evidence-based rationale for developing and funding ED-based programs to address and treat OUDs.

This flyer describes a special webinar series brought to you from the TMF Quality Innovation Network-Quality Improvement Organization (QIN-QIO) and other QIN-QIOs across the country. The webinars will share the latest strategies, interventions and targeted solutions for ensuring that all people have access to medication for opioid use disorder (MOUD) treatment.

This guide includes evidenced-based strategies and resources that first responder agencies, their partners and communities can use to link people who use drugs (PWUD) to substance-use services. The guide also examines things to consider when implementing approaches to support PWUD.

Health care providers can give patients this menu of ways to take the edge off pain without using medications.

This toolkit provides easy-to-adapt policies and procedures for nursing homes that need to implement or improve their emergency response to opioid overdose, which includes naloxone administration.

Listen to these podcasts to learn more about substance use disorder (SUD) and why it should be seen as a chronic disease. Each episode describes how health care providers are striving to end the stigma that is associated with SUD.

This article summarizes a 2019 study that found that the population rate of emergency department visits related to substance use disorders was highest among Black non-Hispanic individuals. Understanding how this and other findings can help highlight potential inequities in care.

This article focuses on five federal policies that have implications for accessing and treating opioid use disorder.

Listen to this podcast to get a better understanding of how the Mainstream Addiction Treatment (MAT) Act changes how providers can treat people with substance use disorders. The podcost describes the new training requirements for clinicians who may need to provide the appropriate treatment of pain.

This webinar recording describes a hospital and community health center collaboration that works to address the underlying needs of the patients who are most likely to become frequent visitors to hospital emergency rooms. The goal is to improve their quality of life outcomes and reduce readmissions while supporting substance users in central Houston.

This guide shares FDA-approved formulations of buprenorphine for Opioid Use Disorder and pain management. Also included: a brief history of buprenorphine and its analgesic effects.

This tool assists clinicians in switching patients from full opioid agonists to buprenorphine, a partial mixed opioid agonist for pain management. Note: the information in this document should not be considered medical advice and is not a substitute for individualized patient or client care and treatment decisions.

Treating chronic pain in light of the U.S. opioid overdose epidemic was the topic of the June 2023 episode of the Centers for Disease Control and Prevention's "Contagious Conversations." Dr. Chris Jones discusses how physicians are handling these challenges.

In this webinar recording, Andrea Yatsco, PhD, and a certified alcohol and drug counselor/licensed chemical dependency counselor, provides an overview of substance abuse disorder. In this first of a nine-part series, Dr. Yatsco asks participants to consider what causes addiction and to examine how language can stigmatize those who have a substance use disorder.

This article explains why it's important for patients to ask their provider questions when they get a new prescription. This is especially important when patients get a prescription for an opioid pain medicine, such as hydrocodone, oxycodone or morphine.

This article shares findings from a study conducted in November and December of 2021. Clinicians and staff at behavioral health clinics from two rural counties participated. Among the conclusions: Naloxone training can be beneficial for rural clinicians and staff who may need to respond quickly to someone experiencing an opioid overdose.

This article describes research showing that provisions made during the COVID-19 pandemic to authorize telehealth expansion and Medications for Opioid Use Disorder (MOUD) resulted in lowering the odds of fatal drug overdose.

The U.S. Food and Drug Administration has approved an over-the-counter naloxone nasal spray. Called Narcan, the medicine that can reverse an opioid-related overdose can now be purchased in drug, convenience and grocery stores, as well as at gas stations and online.

This article explores the impact the COVID-19 pandemic has had on mental health and substance use, from before and after the pandemic.

This new index is designed to assess the “recovery environment” in each U.S. county. The tool provides information on the availability of different treatment options, support systems for people in recovery, and social factors such as housing costs, transportation, and more.

This motivational postcard from the CDC provides awareness that there is a way out of addiction, there is hope, and recovery is possible.

This Opioid Patient Prescriber Agreement from the Food and Drug Administration (FDA) can be shared with patients to help them make informed decisions about opioid treatment for acute or persistent pain and encourage safe and appropriate use.

This infogram from National Institute for Health Care Management (NIHCM) provides a high-level overview of the community-level strategies to reduce drug overdose deaths include promoting evidence-based solutions in prevention, harm reduction, treatment and recovery efforts.

Medicine take back options are the best way to safely dispose of unused or expired prescription and nonprescription (for example, over the counter) medicines. Use this U.S. Food & Drug Administration (FDA) site to find drug take back locations.

The Screener and Opioid Assessment for Patients with Pain- Revised (SOAPP®-R) is a tool for clinicians to help determine how much monitoring a patient on long-term opioid therapy might require.

Through its Shine a Light on Stigma campaign, Superior Health--a Quality Innovation Network – Quality Improvement Organization--is encouraging individuals and organizations to pledge their commitment to using non-stigmatizing, person-centered language when interacting with people with substance use disorder.

This resource offers general recommendations for treating chronic pain. Included are guidelines and tools for determining when to prescribe opioids. From the Michigan Department of Health and Human Services and the University of Michigan's Injury Prevention Center.

Fulfill state-mandated requirements while learning best practices for managing patients' pain through the free New England Journal of Medicine (NEJM) Knowledge+ Pain Management and Opioids CME module. The module is offered in partnership with Boston University School of Medicine's Safer/Competent Opioid Prescribing Education (SCOPE of Pain) program.

Download this two-page handout the TMF Quality Innovation Network developed to ensure providers offer effective pain management and care of patients with opioid use disorder (OUD).

This document has links to the Prescription Drug Montoring Programs in Arkansas, Mississippi, Nebraska, the U.S. territory of Puerto Rico and Texas.

The National Naloxone Map, maintained by New America, to see where naloxone is available in your state. (If the interactive map doesn’t appear when you click on the link, try copying and opening the link in a different browser.)

Pain continues to be the one of the most common reasons many patients seek medical care in the United States, writes the American Medical Association (AMA), The AMA Pain Care Task Force, formed in 2018, explores safe and effective ways to care for patients with undertreated, mistreated pain and chronic pain. This document explains the AMA's principles of pain care.

Opioid use disorder (OUD) is a chronic, relapsing condition, according to the AAFP. This AAFP practice manual proposes that OUD treatment is within the family physician’s scope of practice and guides primary care providers in incorporating opioid screening and brief interventions, as well as evidence-based treatment.

Operation Naloxone, funded by a SAMHSA grant program, is intended, in part, to prepare, locate and implement trainings across Texas in opioid awareness, overdose prevention and naloxone use. Naloxone counters the effects of opioid overdoses by allowing overdose victims to resume normal breathing.

Use the Opioid Adverse Drug Event Review Tool, created by Health Quality Innovators (HQI), to document what happened and identify next steps to avoid future adverse drug events.

Hospitals and other health care facilities can download this tool from TMF Health Quality Institute to help them assess their readiness to prevent or react to an adverse drug event.

A brief, self-report screening tool designed for use with adult patients in primary care settings to assess risk for opioid abuse among those prescribed opioids for treatment of chronic pain.

The Substance Abuse and Mental Health Services Administration (SAMHSA) maintains this directory, which lists programs available in the United States. Access your state from the drop-down menu.

This Centers for Disease Control and Prevention fact sheet provides clinical guidance on dosage of opioids for treatment of chronic pain.

Medication reconciliation is a complex process that impacts all patients as they move through various health care settings. This toolkit item provides tips for conducting a patient medication interview.

Download this tool from the Center to Advance Palliative Care. Some sections of the form should be filled out by the practice’s clinician; other sections should be filled out by the physician.

This TMF Quality Innovation Network change package provides a menu of options from which you can select specific interventions to develop an action plan that improves opioid-related outcomes and increases access to behavioral health services.

Use this U.S. map to locate physicians authorized to treat opioid dependency with buprenorphine. Language assistance available for Spanish and multiple languages.

Give this resource to patients with high pain levels to help them learn when to call the doctor or visit an emergency room.

TMF Quality Innovation Network, en virtud del contrato con CMS, preparó este paquete para facilitar el cambio y proporcionar a las comunidades estrategias para combatir el abuso, el uso inapropiado y las sobredosis de opioides y aumentar el acceso a los servicios de salud del comportamiento.